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Abstract
Aim: To investigate the correlation between breast cancer in Greek women and ABO blood
groups.
Material-methods: In 166 female patients with breast cancer factors such as blood group,
histological type, family history, presence or absence of nodal and/or distant metastases were
examined. These patients had similar demographic, clinical, surgical, immunohistochemical,
laboratory, and follow-up data and this group is representative of general population of women in
Greece.
Results: The ductal type of breast cancer was differentially distributed in blood groups Rh (+) (P
≤ 0.001). In patients with A (+) blood group the ductal type of breast cancer was present in 49.6%
of cases, in relation to the other blood groups and in AB blood group the same type occurred rarely
(3.6%). Rh (+) women with positive family history were more often found in A blood group. The
relative risk of metastasis in Rh (-) patients was 4.2 times higher than that in Rh (+) patients. Among
Rh (+) patients, the relative risk of metastasis was 1.29 times higher in A blood group than in other
blood groups.
Conclusion: Blood group A is often associated with ductal breast cancer (49.6%), in contrast to
the other blood groups and particularly to blood group AB (3.6%). Blood group A and, particularly,
A (-) has the worst prognosis of all.
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Introduction
The role of ABO/Rh blood group as a prognostic factor in
breast cancer has been examined in the past; however,
existing data are surprisingly few and the prognostic role
of blood group remains controversial [1]. There is how-
ever evidence that ABO blood groups may have impor-
tance, since the antigens of blood groups seems to have a
significant biological role in the immunological system,
thereby promoting the development of some tumors,
including breast cancer [2]. The aim of this study is to
investigate the presence of a possible association between
breast cancer and blood groups ABO and Rh.
Materials and methods
Blood samples were collected from 166 women with
breast cancer during their preoperative control and fol-
low-up, following mastectomy, in Laiko General Hospi-
tal. These patients had similar demographic, clinical,
surgical, immunohistochemical, laboratory, and follow
up data. This group was representative of Greek women
among the general population. Factors like family history,
clinical/surgical findings, blood group, histological/
immunohistochemical findings (including type of cancer,
degree of malignancy, and hormone receptor status), and
the presence of nodal and/or distant metastases were
investigated. Three hundred women with benign breast
diseases were used as a control group to allow statistical
analysis. This control group is a representative group at
national level in regard to the ABO blood group system
and Rh status distribution.
Statistical analysis was performed by the Epidemiology
Sector of the National Institution of Public Health.
Descriptive statistics were calculated for all variables.
Odds ratios with 95% of confidence intervals were gener-
ated in case that the essential statistical norms occurred
and x2 test, for possible association of examined factors
and measurement was applied, and whenever possible,
the relative risk (RR) was calculated, for each variable sep-
arately [3-5].
Results
Mean age of patients was 55.31 years (range, 25 – 86 yrs).
Tumor size ranged from 1 to 9 cm (mean, 2.77 cm). The
most common type of breast cancer was ductal (n = 146),
followed by combined (n = 11) and lobular (n = 9). Met-
astatic nodal disease was present in 85 patients, while 35
patients had distant metastases. Invasive breast cancer was
diagnosed in 119 patients, while non-invasive in situ in
47 patients. Of all 166 patients of the study, 86 were pro-
gesterone and estrogen receptors positive (PR + and ER +),
15 patients were PR +, and 20 were ER +. Data regarding
correlation between histological type of breast cancer,
family history, presence of distal metastatic disease and
ABO/Rh blood groups are presented in Tables 1, 2, 3. In
Table 3: Blood groups ABO/Rh in women with Metastasis and 
Breast Cancer
Metastasis
Blood Groups YES NO
A Rh (+) 16 59
A Rh (-) 2 2
B Rh (+) 5 15
B Rh (-) 1 2
AB Rh (+) 2 6
AB Rh (-) 1 0
O Rh (+) 7 46
O Rh (-) 1 1
Total 35 131
Table 1: Blood groups ABO/Rh and Histological types of Breast 
Cancer.
Histological Types
Ductal Lobular Combined
Blood
Groups
A Rh (+) 68 2 5
A Rh (-) 4 0 0
B Rh (+) 19 1 0
B Rh (-) 2 0 1
AB Rh (+) 5 2 0
AB Rh (-) 1 0 1
O Rh (+) 45 4 4
O Rh (-) 2 0 0
Total 146 9 11
Table 2: Blood groups ABO/Rh in women with family history and 
Breast Cancer.
Family History
YES NO
Blood Groups
A Rh (+) 21 54
A Rh (-) 2 2
B Rh (+) 4 16
B Rh (-) 0 3
AB Rh (+) 3 5
AB Rh (-) 0 1
O Rh (+) 16 37
O Rh (-) 2 0
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table 4 the distribution of blood groups (ABO/Rh) in the
control group is presented. No positive correlation
between age, size of the lump, nodal metastases, degree of
malignancy or presence of progesterone/estrogen recep-
tors and ABO blood groups system and Rh status, was
found. Ductal breast cancer was found more frequently in
patients with A blood group (49.6%) in relation to the
other blood groups (P ≤ 0.001), whereas it was much
more rare in patients with AB blood group (3.6%) (Table
5). Rh (+) patients with a positive family history have
more often A blood group and less often AB or B blood
group (P ≤ 0.001) (Table 6). The relative risk in Rh (-)
patients for distant metastasis was 4.2 times higher com-
pared to Rh (+) patients (P ≤ 0.001) (Table 7). However,
among Rh (+) patients, the relative risk for distant metas-
tasis was 1.29 times higher in A blood group compared to
other blood groups (Table 8). As far as distant metastases
are concerned in relation to each Rh(+) ABO blood group,
it seems that they occur more frequently in A blood group,
comparing to the rest ABO blood groups (P ≤ 0.001)
(Table 9).
An abnormal distribution of ductal histological type in Rh
(+) patients was noted (P ≤ 0.001). Ductal breast cancer
occurred more frequently in Rh (+) patients, regardless of
the ABO blood group (P ≤ 0.001).
Discussion
The role of genetic factors in the development of cancer is
widely accepted. During the last two decades, the role of
inheritance in breast tumorigenesis has been clearly estab-
lished, mainly after the description of BRCA1/2 and other
genes. Alexander in 1921 reported that patients with
blood group B and AB were more vulnerable to develop
malignancy which can be more aggressive than neoplasms
occurring in patients with other blood groups [6]. Aird
and Bentall found an association between blood group A
and gastric cancer [7]. This was subsequently confirmed
by other investigators, which showed a further association
between blood group A and pernicious anemia [8-10].
Pandey et al showed an increased frequency of carcinoma
of the gallbladder in blood groups A and AB [11]. Specif-
ically regarding breast cancer, Vogel reported that ABO
blood groups can potentially influence the prognosis,
being an independent prognostic factor [9]. Other groups
of investigators have also recognized ABO blood groups
as a predisposing or prognostic factor in breast cancer
[2,9,12-14]. Previous studies have shown that women
with A blood group are generally prone to develop neo-
plasms with poor prognosis and aggressive biological
behavior and that these women represent a significant
percentage among breast cancer patients, higher than the
actual percentage of A blood group among the general
feminine population [10,12,13]. In contrast, women with
O blood group may have some "protection" against the
development of breast cancer; even when these women
have breast cancer, prognosis is usually more favorable
[12]. Women with AB blood group have similarities with
the A blood group. In contrast, women with B blood
Table 7: Rhezus Blood Groups in women with Metastasis of 
Breast Cancer.
Rhezus Blood Groups Metastasis Total
YES NO
Rh (+) 30 126 156
Rh (-) 5 5 10
Table 5: Blood Groups ABO/Rh(+) and Histological Ductal type 
of Breast Cancer.
Blood Groups Histological Ductal Type
A Rh (+) 68
B Rh (+) 19
AB Rh (+) 5
O Rh (+) 45
Total 137
Table 6: Blood Groups ABO/Rh(+) in women with Family 
History of Breast Cancer.
Blood Groups Family History
YES NO
A Rh(+) 21 54
Other Blood Groups Rh(+) 23 58
Total 44 112
Table 4: The distribution of 300 Persons/controls regarding 
Blood Groups ABO/Rh.
Blood Groups Persons/Controls Percentage %
A 130 43.3%
B 29 9.6%
AB 17 5.6%
O 124 41.3%
Rh (+) 267 85%
Rh (-) 33 15%International Seminars in Surgical Oncology 2009, 6:14 http://www.issoonline.com/content/6/1/14
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group have similarities with women of O blood group,
especially when no family history exists. An interesting
observation of some investigators is that breast cancer
patients with blood group B are at a higher risk of being
re-affected by breast malignancy compared with women
of other blood groups [15]. This may be partially due to
the fact that women with blood group B have better prog-
nosis.
This study showed that a positive family history is more
commonly found in Rh (+) patients irrelevantly of blood
groups ABO. Rh (+) women with positive family history
are more often presented in blood group A and less often
in blood groups AB and B. Ductal type occurs more fre-
quently in Rh (+) patients regardless of the blood group
ABO. In Rh (+) patients, ductal breast cancer is differen-
tially distributed and is commonly observed in patients
with blood group A. The relative risk of metastasis in Rh (-
) patient was 4.2 times higher compared to Rh (+)
patients. Among Rh (+) patients the relative risk of metas-
tasis in blood group A was 1.29 times higher compared
with the risk in the other blood groups. Of all blood
groups, group A and especially Rh (-) group A was associ-
ated with the worse prognosis.
Based on these data, ABO/Rh blood group could be used
as a prognostic factor in breast cancer patients. This use of
blood groups is an interesting proposition, given that the
determination of blood group requires a simple and
cheap examination. However, further studies with larger
number of patients are needed to clearly establish the role
of ABO/Rh blood groups as a prognostic factor in breast
cancer patients.
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